BCRX: Target practice for shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : BCRX: Target practice for shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: J.Y. Wang who wrote (83)	11/1/1999 2:52:00 AM
From: Wolff	Read Replies (1) of 96

BCRX has lost as much money as it stands to gain from the NA inhibitor compound under the best case scenerios as published by the 2ndary offering broker. The broker Smith Barney took the company, IPO, makes a market in the stock, and is the lead of the secondary. The product pipeline absolutely sparse, and the company is redirecting is efforts into finding drugs from discovering firms and taking them farther along, which ironically is what they themselves are supposed to be. The cause of the buying is believed to be artifical support via the offering firms in order to foster a good market to dump the 2 Million shares, (and 300K over allotment) JY this stock is the most manipulated real company I have seen, yes the company is real just tremendously over valued, I am more used to seeing this type of market price manipulation on OTC:BBs But what can I say I am learning on this one too wolff

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next